RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin.
RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin.
复制标题
DOI:
10.1016/j.colsurfb.2016.03.077
复制
发表时间:
2016-08
期刊:
影响因子:
--
通讯作者:
Luzhong Zhang;Guicai Li;Ming Gao;Xin Liu;B. Ji;Ruheng Hua;Y. Zhou;Yumin Yang
中科院分区:
文献类型:
--
作者:
Luzhong Zhang;Guicai Li;Ming Gao;Xin Liu;B. Ji;Ruheng Hua;Y. Zhou;Yumin Yang
Recently, chemotherapy-based polymeric nanoparticles have been extensively investigated for solid tumor treatment. Tumor targeted nanoparticles demonstrated great potential for improved accumulation in the tumor tissue, superior anticancer activity and reduced side effects. Thus, inulin-ibuprofen polymer was synthesized by esterification between inulin and ibuprofen, and RGD targeted epirubicin (EPB) loaded nanoparticles were prepared by the self-assembly of inulin-ibuprofen polymer and in situ encapsulation of EPB. RGD conjugated EPB loaded nanoparticles were characterized by dynamic light scattering (DLS) and transmission electron microscope (TEM). The EPB release from the nanoparticles showed pH-dependent profile and accelerated by the decreased pH value, which would favor the effective drug deliveryin vivo. Intracellular uptake analysis suggested that RGD conjugated nanoparticles could be easily internalized by the cancer cells.In vitrocytotoxicity revealed that RGD conjugated EPB loaded nanoparticles exhibited the better antitumor efficacy compared with non-conjugated nanoparticles. More importantly, RGD conjugated EPB loaded nanoparticles showed superior anticancer effects and reduced toxicity than free EPB and non-conjugated nanoparticles byin vivoantitumor activity, EPB biodistribution and histology analysis.